ResMed Inc. (ASX: RMD) shares have hit a 52-week low, but the valuation, earnings growth, and sleep health opportunity look ...

ResMed’s first quarter saw the company deliver revenue and earnings above Wall Street expectations, yet the market responded ...

Any time I stray from my skin-care routine — whether I’m traveling or had an extra busy week — I turn to face masks for help. They provide a high dose of hydration if I’m dry or help calm breakouts.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

SAN DIEGO – Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, ...

If you’re having trouble sleeping, a sleep mask is one of the most cost-effective and safe ways to improve your chances of falling and staying asleep. Even small sources of light, such as from car ...

Expanding from its core sleep apnoea franchise, Resmed has paid $500 million to treat the common restless leg syndrome.

Resmed Inc () has held its Q3 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for sma ...

ResMed (NYSE:RMD) reported third-quarter fiscal 2026 results highlighted by revenue growth, gross margin expansion, and higher non-GAAP earnings per share, while also announcing a CFO transition and a ...

Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales ...

ResMed shares (ASX: RMD) opened May at a fresh two year low of A$28.40 despite delivering third-quarter results that beat analyst expectations across revenue, earnings, and margins, underscoring a ...

Q3 reiterated FY 2026 gross margin range “62% to 63%” (CFO Sandercock), consistent with Q2’s updated FY 2026 gross margin range.